Ken-ichi Hatanaka

Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist

Yasuharu Kimura, Ken-ichi Hatanaka, Yuki Naitou et al. · European Journal of Pharmacology · 2003 · 52 citations · Full text

Biochemistry, Functional Selectivity, Medicine +5

Biochemical profile of YM992, a novel selective serotonin reuptake inhibitor with 5-HT2A receptor antagonistic activity

Ken-ichi Hatanaka, Tamako Nomura, Koichi Hidaka et al. · Neuropharmacology · 1996 · 37 citations

Biochemistry, Medicine, Psychotropic Medication +6

Synthesis and structure–activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists

Itsuro Shimada, Kyoichi Maeno, Kenichi Kazuta et al. · Bioorganic & Medicinal Chemistry · 2007 · 35 citations · Full text

Molecular Pharmacology, Medicine, 5-Ht2c Receptor Agonists +6

Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex

Ken-ichi Hatanaka, Shin‐ichi Yatsugi, Tokio Yamaguchi · European Journal of Pharmacology · 2000 · 26 citations

Acute Treatment, Neurophysiology, Neuroanatomy +15

Synthesis and structure–activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists

Itsuro Shimada, Kyoichi Maeno, Yutaka Kondoh et al. · Bioorganic & Medicinal Chemistry · 2007 · 10 citations · Full text

Molecular Pharmacology, Medicine, 5-Ht2c Receptor Agonists +7